Genesis HealthCare (GEN) Tops Q3 EPS by 1c, provides guidance

Genesis HealthCare (NASDAQ: GEN) reported Q3 EPS of $0.64, $0.01 better than the analyst estimate of $0.63. Revenue for the quarter came in at $1.24 billion versus the consensus estimate of $1.2 billion.

GUIDANCE:

Genesis HealthCare sees Q4 2026 EPS of $0.64-$0.66, versus the consensus of $0.65. Genesis HealthCare sees Q4 2026 revenue of $1.24-1.26 billion, versus the consensus of $1.24 billion.

Genesis HealthCare sees FY2026 EPS of $2.54-$2.56, versus the consensus of $2.54. Genesis HealthCare sees FY2026 revenue of $4.955-4.975 billion, versus the consensus of $5.176 billion.

For earnings history and earnings-related data on Genesis HealthCare (GEN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Lion Copper & Gold names Millie Paredes as CFO and corporate secretary
• Chinese carmakers exploring Canada’s EV import quota, Joly says